Showing 261-270 of 328 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Network for Pancreatic Organ Donors – nPOD | University of Florida | Mark Atkinson | Cures | 01-October-2023 to 30-September-2026 | $8,100,000.00 |
| Deep Learning-based Analyses of Pancreatic Islet Beta-Cell Heterogeneity and MRI Pancreas Volume as Biomarkers to Improve Understanding of Type 1 Diabetes Progression | University of Florida | Sarah Kim | Cures | 01-June-2022 to 31-May-2026 | $750,000.00 |
| Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2 | University of Florida | Todd Brusko | Cures | 01-September-2024 to 31-August-2026 | $500,000.00 |
| Achieving immune protection in islet transplantation by combining peptide-loaded nanoparticles with conformal coating of islets | University of Kansas Medical Center Research Institute, Inc. | Hubert Tse | Cures | 01-April-2024 to 31-March-2026 | $599,998.25 |
| Determining how NKG2D signaling drives autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-September-2023 to 31-August-2026 | $750,000.00 |
| Engineering a novel Treg population to control autoimmune diabetes | University of Kansas Medical Center Research Institute, Inc. | Mary Markiewicz | Cures | 01-April-2025 to 31-March-2026 | $199,999.62 |
| Enabling studies to advance intra-lymph node depots as a durable antigen-specific immunotherapy for T1D | University of Maryland | Christopher Jewell | Cures | 01-February-2023 to 31-January-2026 | $989,997.00 |
| A Cure for Type 1 Diabetes | University of Massachusetts Medical School | David Harlan | Cures | 01-October-2022 to 30-September-2025 | $12,998,645.40 |
| A Cure for Type 1 Diabetes | University of Massachusetts Medical School | David Harlan | Cures | 01-October-2025 to 30-September-2029 | $16,000,000.00 |
| In vivo interactions and trafficking of islet antigen-specific human effector T cells and Tregs | University of Massachusetts Medical School | Michael Brehm | Cures | 01-November-2024 to 31-October-2027 | $825,000.00 |